Showing results (301-310 of 352) with videos related to
Sort By:
Pageof 36
Inflammatory Bowel Diseases|June 13, 2018
Effect of Social Support on Psychological Distress and Disease Activity in Inflammatory Bowel Disease PatientsVered Slonim-Nevo, Orly Sarid, Michael Friger, et al.Alimentary Pharmacology & Therapeutics|February 3, 2023
Randomised clinical trial: Psychological intervention improves work productivity and daily activity by reducing abdominal pain and fatigue in Crohn's diseaseShirley Regev, Doron Schwartz, Orly Sarid, et al.Advances in Therapy|July 13, 2026
Estimating Utility Values Using the DMD-QoL: A Disease-Specific Preference-Based Measure for Duchenne Muscular Dystrophy (DMD)Andrea Bever, Shelagh M Szabo, Pramoda Jayasinghe, et al.European Journal of Gastroenterology & Hepatology|March 29, 2017
Effect of threatening life experiences and adverse family relations in ulcerative colitis: analysis using structural equation modeling and comparison with Crohn's diseaseVered Slonim-Nevo, Orly Sarid, Michael Friger, et al.Health Economics|May 16, 2020
Growth and capacity for cost-effectiveness analysis in AfricaAri D Panzer, Joanna G Emerson, Brittany D'Cruz, et al.Journal of the American Geriatrics Society|April 14, 2020
Racial and Ethnic Differences in Knowledge About One's Dementia StatusPei-Jung Lin, Joanna Emerson, Jessica D Faul, et al.Expert Review of Pharmacoeconomics & Outcomes Research|April 19, 2023
Recommendations for economic evaluations of cell and gene therapies: a systematic literature review with critical appraisalMondher Toumi, Omar Dabbous, Samuel Aballéa, et al.Health Affairs (Project Hope)|April 12, 2012
In a survey, marked inconsistency in how oncologists judged value of high-cost cancer drugs in relation to gains in survivalPeter A Ubel, Scott R Berry, Eric Nadler, et al.World Journal of Gastroenterology|March 2, 2017
Simple pain measures reveal psycho-social pathology in patients with Crohn's diseaseShmuel Odes, Michael Friger, Ruslan Sergienko, et al.Health Policy (Amsterdam, Netherlands)|November 12, 2021
Variation in market access decisions for cell and gene therapies across the United States, Canada, and EuropeSean Tunis, Eve Hanna, Peter J Neumann, et al.Pageof 36